PharmiWeb.com - Global Pharma News & Resources
22-Sep-2023

Future of Medicine: Digital Therapeutics Market Surges at 24.4% CAGR, Targets US$ 42.5 Billion by 2032 | FMI

Global Digital Therapeutics Market Surges to US$ 4.8 Bn in 2022, Anticipates Staggering 24.4% CAGR, Poised to Hit US$ 42.5 Bn by 2032 To infiltrate and disrupt the healthcare sector, IT companies are producing and acquiring digital therapies. Players are investigating whether digital medicines might improve quality of life and outcomes while maintaining or lowering total healthcare costs in certain disease areas, as well as how patient data obtained through such products can be used to determine coverage. To attract investors, startups are coming up with innovative digital therapeutic ideas.

Claim Your Report – Featuring Captivating Visuals Inside!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14780

Manufacturers are combining off-patent compounds with medical devices farther up the innovation spectrum, such as altering the mode of administration with better inhalers and auto-injectors. This necessitates a bigger investment in research and development, as well as greater usage of collaboration between molecule producers and device manufacturers.

Mass-market platforms present a significant possibility for interaction at scale. Manufacturers of consumer gadgets, namely smartphones and smartwatches, have included healthcare services and encouraged third-party developers to create apps for better patient outcomes.

Simultaneously, attempts have been made to improve the quality of available apps, with major app shops enforcing certain quality criteria. This is a beneficial development because it is critical to place a premium on the secure storage of research-grade data.

Owing to the above-mentioned factors, the digital therapeutics market will expand at a considerable pace over the assessment period.

Unveiling the assumptions behind the study. Ask an Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-14780

“Increasing awareness regarding digital therapeutics across emerging economies, along with growing adoption of healthcare wearables will continue driving growth in the market over the forecast period,” says an FMI analyst.

Key Takeaways:

  • Combination therapy as a solution is expected to account for an approximate market share value of 4% of the global market in 2022.
  • By application, management is expected to hold a dominant market share value of 1% in the 2022 global market.
  • Central nervous system disorders by indication displayed a CAGR growth value expected to reach 2% by 2032.
  • Direct-to-patients/consumers is a dominant segment in terms of the business model within the global market, carrying an estimated market share value of about8%in 2022.
  • The U.S. is accounted for 3% of the North America digital therapeutics market in 2021.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/customization-available/rep-gb-17480

Key Players:

  1. Teladoc Health, Inc.
  2. Click Therapeutics, Inc.
  3. Welldoc
  4. HYGIEIA
  5. DarioHealth Corp
  6. BigHealth
  7. Orexo AB
  8. Akili Interactive Labs, Inc.
  9. Freespira
  10. Voluntis
  11. Kaia Health
  12. Kaiku Health
  13. Theranica Bio-Electronics Ltd.
  14. Propeller Health
  15. Orexo US, Inc.
  16. TALi Digital Limited
  17. Limbix Health, Inc.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 22-Sep-2023